These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 17656329)

  • 1. Interleukin-6 gene polymorphism and faster progression to end-stage renal failure in chronic glomerulonephritis.
    Buraczynska M; Jozwiak L; Ksiazek P; Borowicz E; Mierzicki P
    Transl Res; 2007 Aug; 150(2):101-5. PubMed ID: 17656329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-1 receptor antagonist gene polymorphism affects the progression of chronic renal failure.
    Buraczynska M; Ksiazek P; Kubit P; Zaluska W
    Cytokine; 2006 Nov; 36(3-4):167-72. PubMed ID: 17224277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of non-HLA genetic variants in end-stage renal disease.
    Ranganath P; Tripathi G; Sharma RK; Sankhwar SN; Agrawal S
    Tissue Antigens; 2009 Aug; 74(2):147-55. PubMed ID: 19497039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation between a gene polymorphism of tumor necrosis factor-alpha (G/A) and end-stage renal disease: a pilot study from north India.
    Manchanda PK; Kumar A; Kaul A; Mittal RD
    Clin Chim Acta; 2006 Aug; 370(1-2):152-7. PubMed ID: 16545788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive value of cytokine gene polymorphisms for the development of end-stage renal disease.
    Babel N; Gabdrakhmanova L; Hammer MH; Schoenemann C; Skrypnikov V; Poliak N; Volk HD; Reinke P
    J Nephrol; 2006; 19(6):802-7. PubMed ID: 17173255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of VEGF polymorphism on progression of autosomal dominant polycystic kidney disease.
    Reiterová J; Obeidová H; Lenícek M; Stekrová J; Merta M; Maixnerová D; Vítek L; Viklický O; Tesar V
    Kidney Blood Press Res; 2008; 31(6):398-403. PubMed ID: 19060482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heat-shock protein gene polymorphisms and the risk of nephropathy in patients with Type 2 diabetes.
    Buraczynska M; Swatowski A; Buraczynska K; Dragan M; Ksiazek A
    Clin Sci (Lond); 2009 Jan; 116(1):81-6. PubMed ID: 18518860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin 1 receptor antagonist and tumor necrosis factor-alpha gene polymorphism in patients with end-stage renal failure.
    Shu KH; Cheng CH; Wu MJ; Chen CH; Lee WC
    Ren Fail; 2005; 27(1):53-7. PubMed ID: 15717635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [I/D relationship between polymorphism of ACE gene and progression of chronic glomerulonephritis].
    Kaliev RR; Budaĭchiev AB; Aldashev AA; Mirrakhimov MM
    Ter Arkh; 2005; 77(6):12-5. PubMed ID: 16078593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The research on the relationship between the polymorphism of 1082A/G, anti-inflammatory interleukin-10 gene promoter with its effect of preventing ESRD patients from microinflammation and arteriosclerosis].
    Wu HC; Ling H; Na SP; Xie RJ
    Zhonghua Yi Xue Za Zhi; 2005 Aug; 85(29):2076-80. PubMed ID: 16313808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelial nitric oxide synthase gene intron 4 polymorphism in patients with end-stage renal disease.
    Buraczynska M; Ksiazek P; Zaluska W; Nowicka T; Ksiazek A
    Nephrol Dial Transplant; 2004 Sep; 19(9):2302-6. PubMed ID: 15299097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anaemia of chronic disease in AA amyloidosis is associated with allele 2 of the interleukin-1beta-511 promoter gene and raised levels of interleukin-1beta and interleukin-18.
    Maury CP; Liljeström M; Laiho K; Tiitinen S; Kaarela K; Hurme M
    J Intern Med; 2004 Aug; 256(2):145-52. PubMed ID: 15257727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complement receptor 1 gene polymorphism and cardiovascular disease in dialyzed end-stage renal disease patients.
    Buraczynska M; Ksiazek P; Wacinski P; Zukowski P; Dragan M; Bednarek-Skublewska A
    Hum Immunol; 2010 Sep; 71(9):878-82. PubMed ID: 20538029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complement factor H gene polymorphism and risk of cardiovascular disease in end-stage renal disease patients.
    Buraczynska M; Ksiazek P; Zukowski P; Benedyk-Lorens E; Orlowska-Kowalik G
    Clin Immunol; 2009 Aug; 132(2):285-90. PubMed ID: 19428307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The -786C/T single-nucleotide polymorphism in the promoter of the gene for endothelial nitric oxide synthase: insensitivity to physiologic stimuli as a risk factor for rheumatoid arthritis.
    Melchers I; Blaschke S; Hecker M; Cattaruzza M
    Arthritis Rheum; 2006 Oct; 54(10):3144-51. PubMed ID: 17009241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study of the association of -667 aquaporin-2 (AQP-2) A/G promoter polymorphism with the incidence and clinical course of chronic kidney disease in Korea.
    Kang SW; Kim YW; Kim YH; Sohn HS; Joo H; Kim E
    Ren Fail; 2007; 29(6):693-8. PubMed ID: 17763164
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of MDR1 gene polymorphism on progression of end-stage renal disease.
    Zhang WX; Chen B; Zhang W; Chen N; Yu ZC; Cai WM
    Acta Pharmacol Sin; 2007 Apr; 28(4):579-83. PubMed ID: 17376299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of variants in the interleukin-27 and interleukin-12 gene with nasopharyngeal carcinoma.
    Wei YS; Lan Y; Luo B; Lu D; Nong HB
    Mol Carcinog; 2009 Aug; 48(8):751-7. PubMed ID: 19148899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A promoter polymorphism of the alpha 8 integrin gene and the progression of autosomal-dominant polycystic kidney disease.
    Zeltner R; Hilgers KF; Schmieder RE; Porst M; Schulze BD; Hartner A
    Nephron Clin Pract; 2008; 108(3):c169-75. PubMed ID: 18277079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of IL-4 589 C/T promoter and IL-4RalphaI50V receptor polymorphism with susceptibility to HIV-1 infection in North Indians.
    Chatterjee A; Rathore A; Dhole TN
    J Med Virol; 2009 Jun; 81(6):959-65. PubMed ID: 19382262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.